Why Some People with Pancreatic Cancer live Longer than Others

Newsfeed Image, Light Gray Text On Dark Gray Background
A team of researchers at Memorial Sloan Kettering Cancer Center (MSK) and the Ludwig Center at MSK has shown for the first time why some people with pancreatic cancer live many more years than others. The study, authored by Vinod Balanchandran of MSK, Taha Merghoub of Ludwig MSK and Steven Leach of Dartmouth’s Norris Cotton Cancer Center, has implications for the design of more effective immunotherapies for people with all types of cancer and lays the groundwork for research that could lead to novel cancer vaccines.

Pancreatic cancer is extremely resistant to therapy, with just 7% of people surviving more than five years after diagnosis. Read more . . .